cladribine has been researched along with Chronic Illness in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, E; Butzkueven, H; Buzzard, K; Eichau, S; Girard, M; Hodgkinson, S; Jokubaitis, V; Kalincik, T; Lechner-Scott, J; Monif, M; Oh, J; Prevost, J; Skibina, O; van der Walt, A; Van Pesch, V; Zhong, M | 1 |
| Huang, L; Huang, W; Jin, J; Li, L; Li, M; Li, Y; Mao, X; Meng, F; Peng, Y; Tong, X; Xu, B; Zhang, D | 1 |
| Bojarska-Junak, A; Chocholska, S; Dmoszynska, A; Klimek, P; Kowal, M; Podhorecka, M | 1 |
| Amon, U; Hartmann, K; Horny, HP; Nowak, A | 1 |
| Gibson, LE; Khezri, F; Tefferi, A | 1 |
| Fiebiger, WC; Raderer, M; Trautinger, F; Valencak, J | 1 |
| Kami, M; Kanda, Y; Makimoto, A; Mineishi, S; Nakai, K; Saito, T; Takaue, Y; Tanosaki, R; Tobinai, K; Wakasugi, H | 1 |
| Bernard, F; Bertrand, Y; Chastagner, P; Colin, VM; Donadieu, J; Landman Parker, J; Munzer, M; Ouache, M; Perel, Y; Thomas, C; Vermylen, C | 1 |
| Betticher, DC; Fey, MF; Gratwohl, A; Hess, U; Jenzer, H; Lohri, A; Pagani, O; Pugin, P; Tobler, A; von Rohr, A | 1 |
| Beutler, E; Carrera, CJ; Koziol, JA; McMillan, R; Romine, JS; Sipe, JC | 1 |
| Beutler, E; Frutos, A; Koziol, JA; Romine, JS; Sipe, JC | 1 |
| Algeri, R; Birtolo, S; Forconi, F; Galieni, P; Lauria, F; Raspadori, D; Rondelli, D; Tura, S; Ventura, MA; Zinzani, PL | 1 |
| Brandwein, J; O'Connor, P; Selby, R | 1 |
| Bobzien, W; Lepera, P; Sallah, S; Sallah, W; Wehbie, R | 1 |
| Berentsen, S; Bergheim, J; Hammerstrøm, J; Langholm, R; Shammas, FV; Tjønnfjord, GE; Ulvestad, E | 1 |
| Anderlini, P; Andersson, BS; Andreeff, M; Braunschweig, I; Bruton, J; Champlin, R; Claxton, D; Cohen, A; Davis, M; Donato, M; Gajewski, J; Giralt, S; Ippolitti, C; Khouri, I; Kornblau, S; Molldrem, J; Przepiorka, D; Thall, PF; Ueno, NT; Wang, X | 1 |
2 review(s) available for cladribine and Chronic Illness
| Article | Year |
|---|---|
Mastocytosis - an update.
Topics: Adult; Antineoplastic Agents; Biopsy; Child; Chronic Disease; Cladribine; Codon; Diagnosis, Differential; DNA Mutational Analysis; Exons; Humans; Immunologic Factors; Infant; Interferon-alpha; Mast Cells; Mastocytosis; Proto-Oncogene Proteins c-kit; Skin | 2010 |
Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.
Topics: Antineoplastic Agents; Chronic Disease; Cladribine; Female; Humans; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Psoriasis; Remission Induction; Stomach Neoplasms | 2002 |
4 trial(s) available for cladribine and Chronic Illness
| Article | Year |
|---|---|
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Diseases; Chronic Disease; Cladribine; Female; Humans; Immunocompromised Host; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1994 |
Marrow suppression produced by repeated doses of cladribine.
Topics: Adult; Blood Cell Count; Bone Marrow; Chronic Disease; Cladribine; Depression, Chemical; Double-Blind Method; Female; Humans; Infusion Pumps, Implantable; Male; Multiple Sclerosis; Time Factors | 1994 |
Safety and tolerability of subcutaneous cladribine therapy in progressive multiple sclerosis.
Topics: Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chronic Disease; Cladribine; Disability Evaluation; Disease Progression; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Lymphocyte Count; Male; Middle Aged; Multiple Sclerosis; Safety; Treatment Outcome | 1998 |
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Topics: Acute Disease; Adenosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
11 other study(ies) available for cladribine and Chronic Illness
| Article | Year |
|---|---|
Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Topics: Chronic Disease; Cladribine; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Recurrence | 2023 |
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Topics: Chronic Disease; Cladribine; Decitabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Retrospective Studies | 2023 |
Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents; Apoptosis; B-Lymphocyte Subsets; bcl-2-Associated X Protein; Biomarkers; Bone Marrow Cells; Caspase 3; Chronic Disease; Cladribine; Disease Progression; Enzyme Activation; Humans; Leukemia, Lymphoid; Membrane Glycoproteins; Prognosis; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2010 |
Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series.
Topics: Adult; Aged; Chronic Disease; Cladribine; Female; Histiocytes; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome | 2011 |
Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies.
Topics: Acute Disease; Adolescent; Adult; Aged; Busulfan; Chronic Disease; Cladribine; Cyclophosphamide; Disease-Free Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Middle Aged; Proportional Hazards Models; Recurrence; Stem Cell Transplantation; Survival Rate; Thyroglobulin; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
Fighting leukemia. Survival rates have tripled thanks to new, more effective treatments.
Topics: Acute Disease; Age Factors; Antineoplastic Agents; Benzamides; Chronic Disease; Cladribine; Humans; Imatinib Mesylate; Leukemia; Piperazines; Pyrimidines; Survival Rate | 2003 |
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Cytarabine; Drug Therapy, Combination; Female; Hematologic Diseases; Histiocytosis, Langerhans-Cell; Humans; Infant; Infusions, Intravenous; Male; Pilot Projects; Survival Analysis | 2005 |
A comparison of two neurologic scoring instruments for multiple sclerosis.
Topics: Adult; Chronic Disease; Cladribine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination | 1996 |
2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Agents; Chronic Disease; Cladribine; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Recurrence; Treatment Outcome | 1997 |
The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia.
Topics: Adult; Aged; Blood Protein Disorders; Chronic Disease; Cladribine; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies | 1999 |
No response to cladribine in five patients with chronic cold agglutinin disease.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Chronic Disease; Cladribine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Treatment Failure | 2000 |